FIELD: medicine.
SUBSTANCE: invention refers to ophthalmology and aims at preparing a scleral allograft for scleroplasty in progressive degenerative myopia. Allograft is placed in 0.1% riboflavin solution for 20 minutes. Allograft is then removed from the solution and subjected to ultraviolet crosslinking at wavelength 370 nm at radiation intensity 3 mW/cm2 for 30 minutes with installation of 0.1% riboflavin on the allograft surface every 5 minutes. Thereafter, the allograft is placed in 1.5% Actovegin solution for 30 minutes.
EFFECT: invention provides higher biomechanical stability of the scleral graft with simultaneous provision of its stimulating effect on the haemodynamics of the operated eye.
1 cl, 6 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PROGRESSIVE MYOPIA WITH APPLICATION OF SCLERA COLLAGEN CROSS-LINKING | 2014 |
|
RU2558997C1 |
| METHOD OF TREATING LIMBAL-SCLERAL STAPHYLOMA IN CHILDREN | 2023 |
|
RU2814777C1 |
| REINFORCED TRANSPLANT FOR SCLEROPLASTIC OPERATIONS | 1998 |
|
RU2140242C1 |
| METHOD FOR EVALUATING SCLEROPLASTIC TRANSPLANT POSITION AT POSTERIOR POLE OF MYOPIC EYE | 2016 |
|
RU2633345C1 |
| SCLERA-STRENGTHENING METHOD FOR TREATING THE CASES OF INFANTINE MYOPIA WITH HIGH RISK OF PROGRESSIVE DEVELOPMENT | 1999 |
|
RU2164111C2 |
| TRANSPLANT FOR PERFORMING SCLEROPLASTY | 1999 |
|
RU2161021C2 |
| TRANSPLANT FOR CARRYING OUT SCLEROPLASTIC RAPID PROGRESSING MYOPIA TREATMENT | 2005 |
|
RU2297811C1 |
| METHOD OF COMBINED TREATMENT OF QUICKLY PROGRESSING MYOPIA IN CHILDREN | 2011 |
|
RU2454186C1 |
| METHOD OF TREATING COMPLICATIONS OF VIRAL AND BACTERIAL KERATOCONJUNCTIVITIS IN ANIMALS BY MEANS OF COLLAGEN CROSS-LINKING | 2018 |
|
RU2707792C1 |
| METHOD OF PRODUCING XENOGRAFT WITH MODIFIABLE STIFFNESS PARAMETERS FOR OPHTHALMOSURGERY | 2018 |
|
RU2698041C1 |
